The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what Ryan found was he actually did one study where he gave them access to a low potency product a we'll call it me medium and then a high and what you ended up if you look at the data is the one the rats like the best was the medium potency product interesting and if you gave them the high potency product they would actually take less Vape hits off that than they would off the lower ones
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.